Nisreen Akel

2.0k total citations
31 papers, 1.5k citations indexed

About

Nisreen Akel is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Nisreen Akel has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Physiology. Recurrent topics in Nisreen Akel's work include Bone Metabolism and Diseases (12 papers), Bone health and treatments (8 papers) and TGF-β signaling in diseases (5 papers). Nisreen Akel is often cited by papers focused on Bone Metabolism and Diseases (12 papers), Bone health and treatments (8 papers) and TGF-β signaling in diseases (5 papers). Nisreen Akel collaborates with scholars based in United States, Spain and United Kingdom. Nisreen Akel's co-authors include Larry J. Suva, Dana Gaddy, Manali Bendre, Robert A. Skinner, Donna Montague, Daniel S. Perrien, Frances L. Swain, Richard W. Nicholas, Dana Gaddy-Kurten and Kristy M. Nicks and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Nisreen Akel

31 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nisreen Akel United States 16 805 590 210 167 136 31 1.5k
Berno Dankbar Germany 18 842 1.0× 447 0.8× 187 0.9× 109 0.7× 130 1.0× 33 1.5k
Katsumi Eguchi Japan 19 1.1k 1.3× 406 0.7× 246 1.2× 112 0.7× 106 0.8× 38 1.7k
Sjur Reppe Norway 21 745 0.9× 205 0.3× 167 0.8× 172 1.0× 184 1.4× 65 1.2k
Nicoletta Bivi United States 19 1.1k 1.4× 540 0.9× 77 0.4× 381 2.3× 250 1.8× 32 1.8k
L. van der Wee-Pals Netherlands 11 870 1.1× 702 1.2× 88 0.4× 458 2.7× 172 1.3× 12 1.4k
T Tamura Japan 7 1.1k 1.4× 941 1.6× 236 1.1× 232 1.4× 131 1.0× 9 1.7k
Matti Ahonen Finland 17 747 0.9× 459 0.8× 633 3.0× 47 0.3× 125 0.9× 50 1.6k
Yuanyu Hu Singapore 11 742 0.9× 313 0.5× 126 0.6× 40 0.2× 59 0.4× 14 1.3k
Céline Bazille France 20 449 0.6× 309 0.5× 216 1.0× 42 0.3× 41 0.3× 54 1.2k
Wolfgang Baum Germany 21 795 1.0× 416 0.7× 110 0.5× 207 1.2× 97 0.7× 37 1.9k

Countries citing papers authored by Nisreen Akel

Since Specialization
Citations

This map shows the geographic impact of Nisreen Akel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nisreen Akel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nisreen Akel more than expected).

Fields of papers citing papers by Nisreen Akel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nisreen Akel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nisreen Akel. The network helps show where Nisreen Akel may publish in the future.

Co-authorship network of co-authors of Nisreen Akel

This figure shows the co-authorship network connecting the top 25 collaborators of Nisreen Akel. A scholar is included among the top collaborators of Nisreen Akel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nisreen Akel. Nisreen Akel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
James, A. Gordon, et al.. (2024). Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice. FASEB BioAdvances. 6(3). 73–84. 3 indexed citations
2.
Türkkahraman, Hakan, et al.. (2024). Sclerostin antibody corrects periodontal disease in type 2 diabetic mice. JCI Insight. 9(16). 1 indexed citations
3.
Akel, Nisreen, Julie Crawford, Qiang Fu, et al.. (2023). CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system. iScience. 26(8). 107428–107428. 4 indexed citations
4.
Marino, Silvia, Nisreen Akel, Shenyang Li, et al.. (2023). Reversal of the diabetic bone signature with anabolic therapies in mice. Bone Research. 11(1). 19–19. 14 indexed citations
5.
Akel, Nisreen, et al.. (2022). Loss of chaperone-mediated autophagy is associated with low vertebral cancellous bone mass. Scientific Reports. 12(1). 3134–3134. 12 indexed citations
6.
Jenjaroenpun, Piroon, Thidathip Wongsurawat, Trudy M. Wassenaar, et al.. (2020). Decoding the epitranscriptional landscape from native RNA sequences. Nucleic Acids Research. 49(2). e7–e7. 186 indexed citations
7.
Akel, Nisreen, et al.. (2017). Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice. JBMR Plus. 2(1). 47–54. 11 indexed citations
8.
Chowdhury, Parimal, Nisreen Akel, Azemat Jamshidi‐Parsian, et al.. (2016). Degenerative Tissue Responses to Space-like Radiation Doses in a Rodent Model of Simulated Microgravity.. PubMed. 46(2). 190–7. 12 indexed citations
9.
Garg, Tarun K., Priyangi A. Malaviarachchi, Veronica MacLeod, et al.. (2016). Myeloma-Derived Exosomes and Soluble Factors Suppress Natural Killer Cell Function. Blood. 128(22). 2066–2066. 7 indexed citations
10.
Fowler, Tristan W., et al.. (2015). Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures. Journal of Cell Science. 128(4). 683–94. 25 indexed citations
11.
Fowler, Tristan W., Kent D. McKelvey, Nisreen Akel, et al.. (2012). Low Bone Turnover and Low BMD in Down Syndrome: Effect of Intermittent PTH Treatment. PLoS ONE. 7(8). e42967–e42967. 38 indexed citations
12.
McKelvey, Kent D., Tristan W. Fowler, Nisreen Akel, et al.. (2012). Low bone turnover and low bone density in a cohort of adults with Down syndrome. Osteoporosis International. 24(4). 1333–1338. 68 indexed citations
13.
Perrien, Daniel S., Kristy M. Nicks, Lichu Liu, et al.. (2011). Inhibin A enhances bone formation during distraction osteogenesis. Journal of Orthopaedic Research®. 30(2). 288–295. 19 indexed citations
14.
Chowdhury, Parimal, et al.. (2011). Pressure Hyperalgesia in Hind Limb Suspended Rats. Aviation Space and Environmental Medicine. 82(10). 988–991. 10 indexed citations
15.
Nicks, Kristy M., Tristan W. Fowler, Nisreen Akel, et al.. (2010). Bone turnover across the menopause transition. Annals of the New York Academy of Sciences. 1192(1). 153–160. 34 indexed citations
16.
Nicks, Kristy M., Daniel S. Perrien, Nisreen Akel, Larry J. Suva, & Dana Gaddy. (2009). Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin. Molecular and Cellular Endocrinology. 310(1-2). 11–20. 43 indexed citations
17.
Suva, Larry J., Susan Russell, Nisreen Akel, et al.. (2008). Platelet Dysfunction and a High Bone Mass Phenotype in a Murine Model of Platelet-Type von Willebrand Disease. American Journal Of Pathology. 172(2). 430–439. 60 indexed citations
18.
Perrien, Daniel S., Nisreen Akel, Paul Edwards, et al.. (2006). Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength. Endocrinology. 148(4). 1654–1665. 83 indexed citations
19.
Perrien, Daniel S., Nisreen Akel, Esther E. Dupont‐Versteegden, et al.. (2006). Aging alters the skeletal response to disuse in the rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 292(2). R988–R996. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026